Patients and healthcare providers can now legally import unapproved cancer medicines through authorized suppliers under the “Patient Import Permit” guidelines of the Central Drugs Standard Control Organization (CDSCO). This allows patients to access drugs that are essential for their treatment but not yet marketed in India. https://www.sshealthconnect.com/blog/why-some-cancer-medicines-are-not-available-in-india